Bojesen SE - Search Results

1

Appraising the causal relevance of DNA methylation for risk of lung cancer.

Battram T, Richmond RC, Baglietto L, Haycock PC, Perduca V, Bojesen SE, Gaunt TR, Hemani G, Guida F, Carreras-Torres R, Hung R, Amos CI, Freeman JR, Sandanger TM, Nøst TH, Nordestgaard BG, Teschendorff AE, Polidoro S, Vineis P, Severi G, Hodge AM, Giles GG, Grankvist K, Johansson MB, Johansson M, Davey Smith G, Relton CL. Battram T, et al. Among authors: bojesen se. Int J Epidemiol. 2019 Oct 1;48(5):1493-1504. doi: 10.1093/ije/dyz190. Int J Epidemiol. 2019. PMID: 31549173 Free PMC article.

2

Integrin beta3 Leu33Pro homozygosity and risk of cancer.

Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Bojesen SE, et al. J Natl Cancer Inst. 2003 Aug 6;95(15):1150-7. doi: 10.1093/jnci/djg005. J Natl Cancer Inst. 2003. PMID: 12902444

3

Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.

Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG; Copenhagen City Heart Study. Bojesen SE, et al. J Am Coll Cardiol. 2003 Aug 20;42(4):661-7. doi: 10.1016/s0735-1097(03)00781-2. J Am Coll Cardiol. 2003. PMID: 12932598 Free article.

4

No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.

Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG. Bojesen SE, et al. Br J Cancer. 2005 Jul 11;93(1):167-71. doi: 10.1038/sj.bjc.6602674. Br J Cancer. 2005. PMID: 15970922 Free PMC article.

5

Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.

Bojesen SE, Kjaer SK, Høgdall EV, Thomsen BL, Høgdall CK, Blaakaer J, Tybjaerg-Hansen A, Nordestgaard BG. Bojesen SE, et al. Endocr Relat Cancer. 2005 Dec;12(4):945-52. doi: 10.1677/erc.1.01083. Endocr Relat Cancer. 2005. PMID: 16322334

6

Increased risk of breast cancer associated with CHEK2*1100delC.

Weischer M, Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG. Weischer M, et al. Among authors: bojesen se. J Clin Oncol. 2007 Jan 1;25(1):57-63. doi: 10.1200/JCO.2005.05.5160. Epub 2006 Jul 31. J Clin Oncol. 2007. PMID: 16880452

7

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Dahl M, et al. Among authors: bojesen se. Am J Respir Crit Care Med. 2007 Feb 1;175(3):250-5. doi: 10.1164/rccm.200605-713OC. Epub 2006 Oct 19. Am J Respir Crit Care Med. 2007. PMID: 17053205

8

Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population.

Ørsted DD, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Ørsted DD, et al. Among authors: bojesen se. J Exp Med. 2007 Jun 11;204(6):1295-301. doi: 10.1084/jem.20062476. Epub 2007 May 29. J Exp Med. 2007. PMID: 17535973 Free PMC article.

9

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.

Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Weischer M, et al. Among authors: bojesen se. J Clin Oncol. 2008 Feb 1;26(4):542-8. doi: 10.1200/JCO.2007.12.5922. Epub 2008 Jan 2. J Clin Oncol. 2008. PMID: 18172190 Review.

10

The common germline Arg72Pro polymorphism of p53 and increased longevity in humans.

Bojesen SE, Nordestgaard BG. Bojesen SE, et al. Cell Cycle. 2008 Jan 15;7(2):158-63. doi: 10.4161/cc.7.2.5249. Epub 2007 Nov 1. Cell Cycle. 2008. PMID: 18256523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page